REKA

IL:CO:REKAH

Rekah Pharmaceutical Industries Ltd.

  • Stock

Last Close

1,431.00

21/11 15:24

Market Cap

181.26M

Beta: -

Volume Today

37

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
100.32M
-
88.41M
11.87%
77.32M
12.54%
81.10M
4.89%
76.85M
5.24%
83.52M
8.67%
93.73M
12.23%
90.91M
3.01%
94.40M
3.85%
average payables
61.68M
-
57.00M
7.58%
51.08M
10.39%
49.70M
2.70%
48.18M
3.06%
56.45M
17.17%
62.55M
10.80%
74.71M
19.43%
83.50M
11.78%
average receivables
119.20M
-
book value per share
13.97
-
14.65
4.85%
10.99
24.98%
15.11
37.45%
13.86
8.22%
13.59
1.96%
14.50
6.69%
15.16
4.52%
14.19
6.35%
13.73
3.27%
capex per share
-0.80
-
-3.53
339.45%
-1.57
55.59%
-1.40
10.58%
-1.72
22.57%
-1.39
19.02%
-3.98
186.11%
-1.65
58.51%
-1.23
25.70%
-0.66
46.53%
-1.01
54.73%
capex to depreciation
-0.64
-
-2.35
266.23%
-1.48
36.98%
-1.38
6.95%
-1.62
17.55%
-1.41
12.96%
-2.69
90.29%
-0.96
64.42%
-0.61
35.92%
-0.27
55.53%
-0.39
41.43%
capex to operating cash flow
-0.37
-
-14.49
3,767.84%
-2.26
84.37%
-0.59
73.99%
-0.69
17.56%
-0.88
26.80%
-1.34
52.46%
-1.67
24.70%
-0.66
60.40%
-0.19
70.98%
-0.41
111.25%
capex to revenue
-0.02
-
-0.09
448.44%
-0.05
43.75%
-0.06
22.89%
-0.08
28.57%
-0.07
7.74%
-0.23
216.39%
-0.07
69.29%
-0.05
25.27%
-0.03
51.74%
-0.04
39.58%
cash per share
2.81
-
2.41
14.03%
3.48
44.36%
2.61
25.20%
2.91
11.54%
2.24
22.82%
3.24
44.22%
1.63
49.52%
1.78
8.83%
1.71
3.90%
days of inventory on hand
243.56
-
201.25
17.37%
186.50
7.33%
202.41
8.53%
218.65
8.02%
186.53
14.69%
181.45
2.72%
164.54
9.32%
157.48
4.29%
146.03
7.27%
days payables outstanding
143.47
-
128.96
10.12%
121.19
6.02%
135.87
12.11%
122.25
10.03%
132.39
8.30%
118.31
10.63%
112.55
4.87%
150.51
33.72%
119.26
20.76%
days sales outstanding
133.54
-
debt to assets
0.51
-
0.28
44.61%
0.29
4.73%
0.27
7.91%
0.28
3.46%
0.39
39.99%
0.40
0.85%
0.38
4.28%
0.34
9.26%
0.37
7.21%
debt to equity
2.06
-
0.74
64.09%
0.90
21.65%
0.55
38.76%
0.56
0.91%
0.93
66.97%
1.00
8.07%
0.96
4.62%
0.95
0.59%
1.15
20.72%
dividend yield
0.06
-
earnings yield
0.10
-
-0.01
110.10%
-0.03
193.99%
-0.05
76.12%
-0.07
20.77%
0.02
137.97%
0.01
51.65%
0.04
192.03%
0.02
29.37%
-0.01
146.12%
-0.04
259.04%
enterprise value
194.03M
-
215.19M
10.91%
265.19M
23.24%
396.49M
49.51%
333.72M
15.83%
346.65M
3.87%
435.36M
25.59%
412.95M
5.15%
311.89M
24.47%
327.02M
4.85%
enterprise value over ebitda
14.22
-
14.99
5.40%
14.98
0.08%
17.27
15.33%
13.28
23.11%
12.79
3.69%
10.88
14.93%
11.35
4.28%
7.75
31.70%
12.56
62.10%
ev to operating cash flow
145.88
-
37.06
74.59%
11.62
68.65%
16.66
43.40%
19.31
15.89%
10.22
47.06%
38.59
277.48%
19.51
49.44%
8.00
59.01%
11.53
44.24%
ev to sales
0.90
-
0.82
8.56%
1.21
48.09%
1.90
56.84%
1.61
15.69%
1.76
9.86%
1.64
7.04%
1.56
4.60%
1.07
31.82%
1.02
4.69%
free cash flow per share
1.34
-
-3.28
345.05%
-0.87
73.36%
0.98
211.75%
0.76
21.98%
0.19
74.68%
-1.01
621.09%
-0.66
34.24%
0.63
195.01%
2.76
339.30%
1.49
46.10%
free cash flow yield
0.09
-
-0.38
511.13%
-0.05
86.35%
0.05
190.32%
0.02
53.89%
0.01
65.02%
-0.05
771.91%
-0.02
51.00%
0.03
209.37%
0.18
556.84%
0.10
43.22%
graham net net
-30.62
-
-15.49
49.43%
-15.10
2.50%
-9.01
40.34%
-6.93
23.09%
-13.29
91.84%
-14.74
10.91%
-17.57
19.22%
-19.27
9.66%
-15.29
20.64%
graham number
5.37
-
13.17
145.24%
16.83
27.85%
28.21
67.60%
14.17
49.77%
8.59
39.37%
17.57
104.48%
14.07
19.92%
7.56
46.26%
13.73
81.57%
income quality
1.40
-
-0.54
138.84%
-1.33
146.16%
-1.30
2.83%
-0.94
27.29%
2.53
368.58%
8.78
246.81%
1.05
88.10%
3.20
206.28%
-19.09
696.46%
-4.10
78.51%
intangibles to total assets
0
-
0.01
Infinity%
0.00
65.36%
0.01
151.05%
0.01
2.00%
0.01
6.63%
0.01
9.81%
0.01
49.90%
0.08
657.65%
0.08
5.99%
0.14
72.41%
interest coverage
2.59
-
0.73
71.62%
0.18
75.73%
1.34
653.79%
2.44
81.46%
3.30
35.36%
2.26
31.54%
3.60
59.34%
2.51
30.26%
2.35
6.50%
interest debt per share
30.14
-
11.60
61.51%
10.48
9.63%
8.83
15.75%
8.12
8.11%
13.09
61.24%
15.08
15.25%
15.02
0.40%
14.02
6.67%
15.79
12.65%
inventory turnover
1.50
-
1.81
21.03%
1.96
7.91%
1.80
7.86%
1.67
7.43%
1.96
17.22%
2.01
2.80%
2.22
10.28%
2.32
4.48%
2.50
7.85%
invested capital
2.06
-
0.74
64.09%
0.90
21.65%
0.55
38.76%
0.56
0.91%
0.93
66.97%
1.00
8.07%
0.96
4.62%
0.95
0.59%
1.15
20.72%
market cap
79.83M
-
47.58M
40.40%
142.60M
199.69%
201.78M
41.50%
341.45M
69.22%
281.12M
17.67%
227.95M
18.91%
305.91M
34.20%
265.73M
13.13%
177.73M
33.12%
167.43M
5.80%
net current asset value
-12.34M
-
30.33M
345.79%
10.12M
66.62%
42.07M
315.53%
47.52M
12.97%
-34.21M
171.99%
-26.75M
21.83%
-42.37M
58.40%
-43.20M
1.96%
-77.81M
80.12%
net debt to ebitda
10.73
-
5.06
52.90%
3.58
29.17%
2.40
33.05%
2.09
12.70%
4.38
109.24%
3.24
26.13%
4.05
25.04%
3.33
17.58%
6.13
83.90%
net income per share
1.52
-
-0.09
106.02%
-0.53
473.59%
-1.15
117.90%
-2.34
104.36%
0.64
127.49%
0.24
62.50%
0.95
291.91%
0.58
38.65%
-0.18
130.84%
-0.61
240.82%
operating cash flow per share
2.14
-
0.24
88.64%
0.69
184.21%
2.38
243.74%
2.48
4.26%
1.58
36.14%
2.97
87.66%
0.99
66.73%
1.85
87.62%
3.42
84.24%
2.50
26.75%
payables turnover
2.54
-
2.83
11.26%
3.01
6.41%
2.69
10.80%
2.99
11.14%
2.76
7.66%
3.08
11.90%
3.24
5.12%
2.43
25.22%
3.06
26.20%
receivables turnover
2.73
-
research and ddevelopement to revenue
0.01
-
0.01
24.21%
0.01
68.57%
0.01
33.12%
0.01
5.60%
0.01
30.14%
0.01
33.18%
0.01
35.80%
0.01
40.13%
0.01
6.26%
return on tangible assets
-0.00
-
-0.01
738.61%
-0.03
151.28%
-0.08
123.57%
0.02
130.69%
0.01
67.95%
0.03
243.96%
0.02
36.92%
-0.00
130.21%
-0.02
233.90%
revenue per share
49.42
-
39.60
19.87%
31.27
21.04%
22.75
27.24%
21.69
4.67%
19.04
12.22%
17.21
9.57%
23.26
35.10%
23.12
0.57%
25.62
10.78%
28.40
10.85%
roe
-0.01
-
-0.04
447.04%
-0.10
190.47%
-0.16
48.69%
0.05
129.95%
0.02
61.75%
0.07
267.34%
0.04
41.30%
-0.01
132.93%
-0.04
252.35%
roic
0.02
-
0.01
62.81%
0.04
561.58%
0.06
39.70%
0.04
27.84%
0.02
52.09%
0.04
110.13%
0.03
24.78%
-0.21
768.41%
0.01
104.20%
sales general and administrative to revenue
0.02
-
0.03
13.80%
0.02
24.30%
0.03
34.09%
0.03
21.94%
0.03
5.13%
0.03
5.09%
0.02
22.45%
0.02
8.39%
0.03
20.34%
0.10
226.69%
shareholders equity per share
13.97
-
14.65
4.85%
10.99
24.98%
15.11
37.45%
13.86
8.22%
13.59
1.96%
14.50
6.69%
15.16
4.52%
14.19
6.35%
13.73
3.27%
stock based compensation to revenue
-0.01
-
0.05
805.18%
0.13
142.12%
0.00
-
0.00
371.12%
0.00
19.47%
0.00
56.27%
tangible asset value
74.19M
-
122.62M
65.28%
103.26M
15.79%
142.30M
37.80%
148.45M
4.32%
152.78M
2.92%
161.41M
5.65%
140.10M
13.21%
126.23M
9.90%
88.78M
29.67%
tangible book value per share
13.58
-
14.61
7.60%
10.76
26.37%
14.82
37.80%
13.60
8.27%
13.38
1.57%
14.14
5.65%
12.27
13.21%
11.06
9.90%
7.84
29.13%
working capital
89.03M
-
138.05M
55.06%
133.85M
3.04%
114.43M
14.51%
117.30M
2.51%
93.00M
20.71%
119.09M
28.06%
123.05M
3.32%
104.11M
15.39%
107.54M
3.29%

All numbers in (except ratios and percentages)